Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy

被引：61

作者：

Jiang, Liwei ^{[1
]}

Wang, Yi-Jun ^{[1
]}

Zhao, Jing ^{[1
]}

Uehara, Mayuko ^{[1
]}

Hou, Qingming ^{[1
,5
]}

Kasinath, Vivek ^{[1
]}

Ichimura, Takaharu ^{[2
]}

Banouni, Naima ^{[1
]}

Dai, Li ^{[1
]}

Li, Xiaofei ^{[1
]}

Greiner, Dale L. ^{[3
]}

Shultz, Leonard D. ^{[4
]}

Zhang, Xiaolong ^{[6
]}

Sun, Zhen-Yu Jim ^{[7
,10
]}

Curtin, Ian ^{[10
]}

Vangos, Nicholas E. ^{[10
]}

Yeoh, Zoe C. ^{[10
]}

Geffken, Ezekiel A. ^{[10
]}

Seo, Hyuk-Soo ^{[7
,10
]}

Liu, Ze-Xian ^{[6
]}

Heffron, Gregory J. ^{[7
]}

Shah, Khalid ^{[8
,9
,11
]}

Dhe-Paganon, Sirano ^{[7
,10
]}

Abdi, Reza ^{[1
,11
]}

机构：

[1] Harvard Med Sch, Transplantat Res Ctr, Brigham & Womens Hosp, Renal Div, Boston, MA 02115 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA

[3] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA

[4] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA

[5] Qingdao Univ, Inst Neuroregenerat & Neurorehabil, Qingdao 266071, Peoples R China

[6] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China

[7] Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA

[8] Harvard Med Sch, Ctr Stem Cell Therapeut & Imaging, Brigham & Womens Hosp, Boston, MA 02115 USA

[9] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA

[10] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA

[11] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA

来源：

CELL | 2020年 / 183卷 / 05期

关键词：

antitumor immune response; cancer-associated fibroblasts; granzyme B; SerpinB9;

D O I：

10.1016/j.cell.2020.10.045

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cancer therapies kill tumors either directly or indirectly by evoking immune responses and have been combined with varying levels of success. Here, we describe a paradigm to control cancer growth that is based on both direct tumor killing and the triggering of protective immunity. Genetic ablation of serine protease inhibitor SerpinB9 (Sb9) results in the death of tumor cells in a granzyme B (GrB)-dependent manner. Sb9-deficient mice exhibited protective T cell-based host immunity to tumors in association with a decline in GrB-expressing immunosuppressive cells within the tumor microenvironment (TME). Maximal protection against tumor development was observed when the tumor and host were deficient in Sb9. The therapeutic utility of Sb9 inhibition was demonstrated by the control of tumor growth, resulting in increased survival times in mice. Our studies describe a molecular target that permits a combination of tumor ablation, interference within the TME, and immunotherapy in one potential modality.

引用

页码：1219 / +

页数：33

共 59 条

[1] IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer
Andersson, Asa
Yang, Seok-Chul
Huang, Min
Zhu, Li
Kar, Upendra K.
Batra, Rai K.
Elashoff, David
Strieter, Robert M.
Dubinett, Steven M.
Sharma, Sherven
[J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (11) : 6951 - 6958
[2] Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9
Annand, RR
Dahlen, JR
Sprecher, CA
de Dreu, P
Foster, DC
Mankovich, JA
Talanian, RV
Kisiel, W
Giegel, DA
[J]. BIOCHEMICAL JOURNAL, 1999, 342 : 655 - 665
[3] Serine Protease Inhibitor 6 Plays a Critical Role in Protecting Murine Granzyme B-Producing Regulatory T Cells
Azzi, Jamil
Skartsis, Nikolaos
Mounayar, Marwan
Magee, Ciara N.
Batal, Ibrahim
Ting, Christopher
Moore, Robert
Riella, Leonardo V.
Ohori, Shunsuke
Abdoli, Rozita
Smith, Brian
Fiorina, Paolo
Heathcote, Dean
Bakhos, Tannous
Ashton-Rickardt, Philip G.
Abdi, Reza
[J]. JOURNAL OF IMMUNOLOGY, 2013, 191 (05) : 2319 - 2327
[4] Self-Renewal Does Not Predict Tumor Growth Potential in Mouse Models of High-Grade Glioma
Barrett, Lindy E.
Granot, Zvi
Coker, Courtney
Lavarone, Antonio
Hambardzumyan, Dolores
Holland, Eric C.
Hyung-song Nam
Benezra, Robert
[J]. CANCER CELL, 2012, 21 (01) : 11 - 24
[5] Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway
Bird, CH
Sutton, VR
Sun, JR
Hirst, CE
Novak, A
Kumar, S
Trapani, JA
Bird, PI
[J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) : 6387 - 6398
[6] Serpins in T cell immunity
Bots, Michael
Medema, Jan Paul
[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (05) : 1238 - 1247
[7] Does the serpin PI-9 protect tumor cells?
Bots, Michael
Offringa, Rienk
Medema, Jan Paul
[J]. BLOOD, 2006, 107 (12) : 4974 - 4975
[8] The efficiency of multi-target drugs: the network approach might help drug design
Csermely, P
Agoston, V
Pongor, S
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (04) : 178 - 182
[9] Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells
D'Eliseo, Donatella
Di Rocco, Giuliana
Loria, Rossella
Soddu, Silvia
Santoni, Angela
Velotti, Francesca
[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
[10] Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion
D'Eliseo, Donatella
Pisu, Paola
Romano, Chiara
Tubaro, Andrea
De Nunzio, Cosimo
Morrone, Stefania
Santoni, Angela
Stoppacciaro, Antonella
Velotti, Francesca
[J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (06) : 1283 - 1294

← 1 2 3 4 5 6 →